Scrip ID
VANTABIO
Vanta Bioscience Limited has intimated the Bombay Stock Exchange about an upcoming Board of Directors meeting scheduled for Saturday, May 30, 2026 at 6:00 PM. The meeting will be held at the company's registered office in Hyderabad.
The primary agenda of the board meeting is to consider and approve both the Standalone and Consolidated Audited Financial Results for the half year and the financial year ended March 31, 2026. Additionally, the board will take note of the Audit Reports issued by the Statutory Auditors on these financial results.
In continuation of the previous intimation dated March 24, 2026, the company confirms that the Trading Window for all designated persons under the company's Insider Trading Policy remains closed from April 1, 2026 until June 1, 2026 (both days inclusive).
The document is signed by Dopesh Raja Mulakala, Managing Director (DIN: 01176660), and was digitally signed on May 26, 2026 at 12:55:15 IST.